All Stories

  1. Heart failure hospitalization with SGLT-2 inhibitors: a systematic review and meta-analysis of randomized controlled and observational studies

    Article • Expert Review of Clinical Pharmacology, March 2019, Taylor & Francis

    Dr Awadhesh Kumar Singh

  2. Spotlight on Canagliflozin 300: review of its efficacy and an indirect comparison to other SGLT-2 inhibitors and long-acting GLP-1 receptor agonists

    Article • Expert Review of Clinical Pharmacology, April 2017, Taylor & Francis

    Dr Awadhesh Kumar Singh

  3. Incretin response in Asian type 2 diabetes: Are Indians different?

    Article • Indian Journal of Endocrinology and Metabolism, January 2015, Medknow

    Dr Awadhesh Kumar Singh

  4. Glucagon-like peptide 1 and dysglycemia: Conflict in incretin science

    Article • Indian Journal of Endocrinology and Metabolism, January 2015, Medknow

    Dr Awadhesh Kumar Singh

  5. Metformin in gestational diabetes: An emerging contender

    Article • Indian Journal of Endocrinology and Metabolism, January 2015, Medknow

    Dr Awadhesh Kumar Singh

  6. Bariatric surgery and diabetes remission: Who would have thought it?

    Article • Indian Journal of Endocrinology and Metabolism, January 2015, Medknow

    Dr Awadhesh Kumar Singh

  7. Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress

    Article • Indian Journal of Endocrinology and Metabolism, January 2015, Medknow

    Dr Awadhesh Kumar Singh

  8. Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight

    Article • Indian Journal of Endocrinology and Metabolism, January 2015, Medknow

    Dr Awadhesh Kumar Singh

  9. Why we need even better formulated premix insulin ?

    Article • Expert Review of Endocrinology & Metabolism, October 2014, Taylor & Francis

    Dr Awadhesh Kumar Singh

  10. This article analyse few untold story about currently available basal insulin

    Article • Indian Journal of Endocrinology and Metabolism, January 2014, Medknow

    Dr Awadhesh Kumar Singh

  11. Why DPP-4 inhibitors (Gliptins) works so effectively in type 2 diabetes: What's new?

    Article • Indian Journal of Endocrinology and Metabolism, January 2014, Medknow

    Dr Awadhesh Kumar Singh